The risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
Damon Asher
Advertisement
Damon Asher, PHD, is associate director Americas vaccine and viral therapies, MilliporeSigma.
Articles by Damon Asher
Advertisement
Latest Updated Articles
Preventing Microbial Contamination of Viral Vaccines and VectorsPublished: October 3rd 2018 | Updated:
Advertisement
Advertisement
